Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Bennett

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Clinics in Geriatric Medicine|September 22, 2009
Drug dosing in the elderly patients with chronic kidney diseaseAli J Olyaei, William M Bennett
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Introduction: academic nephrology 2008William M Bennett, Robert W Schrier
Clinics in Geriatric Medicine|July 16, 2013
Drug dosing in elderly patients with chronic kidney diseaseJessica Lassiter, William M Bennett, Ali J Olyaei
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Analgesia in patients with ESRD: a review of available evidenceManjula Kurella, William M Bennett, Glenn M Chertow
American Journal of Nephrology|November 20, 2009
Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantationFuad S Shihab, William M Bennett, Takeshi F Andoh
The New England Journal of Medicine|January 21, 2011
mTOR inhibitors and autosomal dominant polycystic kidney diseaseJared J Grantham, William M Bennett, Ronald D Perrone
Transplantation|February 10, 2009
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantationFuad S Shihab, William M Bennett, Takeshi F Andoh
Expert Opinion on Drug Safety|February 16, 2005
Cardiovascular complications of immunosuppressive agents in renal transplant recipientsAli J Olyaei, Angelo M Demattos, William M Bennett
American Journal of Nephrology|May 21, 2010
Surveillance and modification of immunosuppression minimizes BK virus nephropathyWilliam M Bennett, Leslie Meyer, Jennifer Ridenour, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 9, 2002
Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicityFuad S Shihab, William M Bennett, Hong Yi, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Clinics in Geriatric Medicine|September 22, 2009
Drug dosing in the elderly patients with chronic kidney diseaseAli J Olyaei, William M Bennett
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Introduction: academic nephrology 2008William M Bennett, Robert W Schrier
Clinics in Geriatric Medicine|July 16, 2013
Drug dosing in elderly patients with chronic kidney diseaseJessica Lassiter, William M Bennett, Ali J Olyaei
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Analgesia in patients with ESRD: a review of available evidenceManjula Kurella, William M Bennett, Glenn M Chertow
American Journal of Nephrology|November 20, 2009
Role of cellular cholesterol in pharmacologic preconditioning with cyclosporine in experimental kidney transplantationFuad S Shihab, William M Bennett, Takeshi F Andoh
The New England Journal of Medicine|January 21, 2011
mTOR inhibitors and autosomal dominant polycystic kidney diseaseJared J Grantham, William M Bennett, Ronald D Perrone
Transplantation|February 10, 2009
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantationFuad S Shihab, William M Bennett, Takeshi F Andoh
Expert Opinion on Drug Safety|February 16, 2005
Cardiovascular complications of immunosuppressive agents in renal transplant recipientsAli J Olyaei, Angelo M Demattos, William M Bennett
American Journal of Nephrology|May 21, 2010
Surveillance and modification of immunosuppression minimizes BK virus nephropathyWilliam M Bennett, Leslie Meyer, Jennifer Ridenour, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 9, 2002
Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicityFuad S Shihab, William M Bennett, Hong Yi, et al.
Pageof 9